Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Laffan

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|June 6, 2003
Dissociation of ABH antigen expression from von Willebrand factor synthesis in endothelial cell linesJames O'Donnell, Michael A Laffan
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 20, 2004
Hunting for the mutation in inherited thrombophiliaKeith Gomez, Michael A Laffan
The New England Journal of Medicine|April 5, 2013
Transfusion for acute upper gastrointestinal bleedingAmit Patel, Michael A Laffan
The New England Journal of Medicine|February 11, 2011
Safety of recombinant activated factor VII in randomized clinical trialsAmit Patel, Nichola Cooper, Michael A Laffan
British Journal of Haematology|March 17, 2010
Monitoring heparin anticoagulation in the acute phase responseJames Uprichard, Richard A Manning, Michael A Laffan
British Journal of Haematology|September 27, 2003
Beta-adrenergic receptor polymorphisms in patients with elevated factor VIII levels with venous thrombosisJames O'Donnell, Richard A Manning, Michael A Laffan
Thrombosis and Haemostasis|August 3, 2002
The relationship between plasma concentration of alpha2-macroglobulin and ABO blood groupJames O'Donnell, Frank E Boulton, Michael A Laffan
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 22, 2006
Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experienceElspeth M Payne, Stephen J Brett, Michael A Laffan
BMJ (Clinical Research Ed.)|August 8, 2014
Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortalityAmit Patel, Michael A Laffan, Umeer Waheed, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2002
Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levelsJames O'Donnell, Frank E Boulton, Richard A Manning, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|June 6, 2003
Dissociation of ABH antigen expression from von Willebrand factor synthesis in endothelial cell linesJames O'Donnell, Michael A Laffan
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 20, 2004
Hunting for the mutation in inherited thrombophiliaKeith Gomez, Michael A Laffan
The New England Journal of Medicine|April 5, 2013
Transfusion for acute upper gastrointestinal bleedingAmit Patel, Michael A Laffan
The New England Journal of Medicine|February 11, 2011
Safety of recombinant activated factor VII in randomized clinical trialsAmit Patel, Nichola Cooper, Michael A Laffan
British Journal of Haematology|March 17, 2010
Monitoring heparin anticoagulation in the acute phase responseJames Uprichard, Richard A Manning, Michael A Laffan
British Journal of Haematology|September 27, 2003
Beta-adrenergic receptor polymorphisms in patients with elevated factor VIII levels with venous thrombosisJames O'Donnell, Richard A Manning, Michael A Laffan
Thrombosis and Haemostasis|August 3, 2002
The relationship between plasma concentration of alpha2-macroglobulin and ABO blood groupJames O'Donnell, Frank E Boulton, Michael A Laffan
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 22, 2006
Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experienceElspeth M Payne, Stephen J Brett, Michael A Laffan
BMJ (Clinical Research Ed.)|August 8, 2014
Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortalityAmit Patel, Michael A Laffan, Umeer Waheed, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 9, 2002
Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levelsJames O'Donnell, Frank E Boulton, Richard A Manning, et al.
Pageof 6